| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | E Carlos Rodriguez-Merchan | |
| Leonard A Valentino | |||
| P2860 | cites work | Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence | Q83461572 |
| Biomaterials in the repair of sports injuries | Q84603765 | ||
| Cartilage lesions of the knee treated with blood mesenchymal stem cells - results | Q86058807 | ||
| A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients | Q88328751 | ||
| Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions | Q24533385 | ||
| Mesenchymal precursor cells in the blood of normal individuals | Q24792739 | ||
| Unicompartmental Knee Osteoarthritis (UKOA): Unicompartmental Knee Arthroplasty (UKA) or High Tibial Osteotomy (HTO)? | Q28066037 | ||
| Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects | Q28203658 | ||
| Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology | Q28305724 | ||
| Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy | Q30545559 | ||
| Investigation of the cause of death in a gene-therapy trial | Q33385315 | ||
| Genetic Modification of Human Peripheral Blood Aspirates Using Recombinant Adeno-Associated Viral Vectors for Articular Cartilage Repair with a Focus on Chondrogenic Transforming Growth Factor-β Gene Delivery | Q33722104 | ||
| Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease | Q33726762 | ||
| The amelioration of cartilage degeneration by photo-crosslinked GelHA hydrogel and crizotinib encapsulated chitosan microspheres | Q33728287 | ||
| Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells | Q34216856 | ||
| Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations | Q34563072 | ||
| Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for gene delivery into rat mesenchymal stem cells | Q34956388 | ||
| In Vivo MRI Tracking of Polyethylenimine-Wrapped Superparamagnetic Iron Oxide Nanoparticle-Labeled BMSCs for Cartilage Repair: A Minipig Model | Q34978019 | ||
| Osteoarthritis gene therapy | Q35629588 | ||
| Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 | ||
| Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells | Q36633333 | ||
| Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury | Q37679296 | ||
| Regenerating cartilages by engineered ASCs: prolonged TGF-β3/BMP-6 expression improved articular cartilage formation and restored zonal structure | Q37690467 | ||
| Cartilage repair and joint preservation: medical and surgical treatment options | Q37960493 | ||
| The treatment of cartilage defects in the knee joint: microfracture, mosaicplasty, and autologous chondrocyte implantation. | Q38020173 | ||
| Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease | Q38048825 | ||
| Regeneration of articular cartilage of the knee | Q38069471 | ||
| Advances and challenges in gene-based approaches for osteoarthritis | Q38134331 | ||
| Medial Unicompartmental Osteoarthritis (MUO) of the Knee: Unicompartmental Knee Replacement (UKR) or Total Knee Replacement (TKR). | Q38266980 | ||
| Cartilage tissue engineering: recent advances and perspectives from gene regulation/therapy | Q38345989 | ||
| Gene therapy for chondral and osteochondral regeneration: is the future now? | Q38634077 | ||
| Impact of mechanical stimulation on the chondrogenic processes in human bone marrow aspirates modified to overexpress sox9 via rAAV vectors | Q38668730 | ||
| Management of knee osteoarthritis. Current status and future trends | Q38822218 | ||
| Customized biomaterials to augment chondrocyte gene therapy | Q38968053 | ||
| Gene Therapy in a Patient with Sickle Cell Disease | Q40313066 | ||
| PEO-PPO-PEO Carriers for rAAV-Mediated Transduction of Human Articular Chondrocytes in Vitro and in a Human Osteochondral Defect Model | Q40655491 | ||
| Alginate hydrogels as synthetic extracellular matrix materials | Q40978578 | ||
| Effect of transfection strategy on growth factor overexpression by articular chondrocytes | Q41846147 | ||
| Endogenous versus exogenous growth factor regulation of articular chondrocytes | Q41982504 | ||
| The basic science of articular cartilage: structure, composition, and function | Q42094020 | ||
| Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach | Q42438194 | ||
| Exogenous insulin-like growth factor-I stimulates an autoinductive IGF-I autocrine/paracrine response in chondrocytes | Q43595031 | ||
| Gene mediated insulin-like growth factor-I delivery to the synovium | Q43741092 | ||
| Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines | Q43837302 | ||
| Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial | Q43890277 | ||
| Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system | Q44036702 | ||
| The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid (PLLA) scaffolds | Q44205732 | ||
| Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles | Q44316476 | ||
| Osteochondral lesions of the knee reconstructed with mesenchymal stem cells - results | Q45182006 | ||
| Gene delivery to cartilage defects using coagulated bone marrow aspirate | Q45252422 | ||
| Enhanced local delivery with reduced systemic toxicity: delivery, delivery, and delivery. | Q45865369 | ||
| Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model | Q45868543 | ||
| Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies | Q45871556 | ||
| Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy | Q45873849 | ||
| Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function | Q45874375 | ||
| Gene Delivery to Joints by Intra-articular Injection. | Q45874835 | ||
| Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. | Q45875499 | ||
| Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation | Q45880338 | ||
| Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). | Q45882616 | ||
| Evaluation of three-dimensional scaffolds prepared from poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for growth of allogeneic chondrocytes for cartilage repair in rabbits | Q46649237 | ||
| Transforming growth factor-beta1 promotes articular cartilage repair through canonical Smad and Hippo pathways in bone mesenchymal stem cells | Q47382053 | ||
| In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice | Q49387533 | ||
| Does a Previous High Tibial Osteotomy (HTO) Influence the Long-term Function or Survival of a Total Knee Arthroplasty (TKA)? | Q49476189 | ||
| Evaluation and comparison of the in vitro characteristics and chondrogenic capacity of four adult stem/progenitor cells for cartilage cell-based repair. | Q50919367 | ||
| Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. | Q51360083 | ||
| Articular cartilage: injuries and potential for healing. | Q52532281 | ||
| Mimicking of Chondrocyte Microenvironment Using In Situ Forming Dendritic Polyglycerol Sulfate-Based Synthetic Polyanionic Hydrogels. | Q52857995 | ||
| A tetracycline expression system in combination with Sox9 for cartilage tissue engineering. | Q53657646 | ||
| Gene therapy for repair and regeneration of bone and cartilage. | Q54241105 | ||
| Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model | Q59359723 | ||
| Anticoagulantly active heparin-like molecules from vascular tissue | Q72814587 | ||
| Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing | Q74148784 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 79-90 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | The archives of bone and joint surgery | Q27725795 |
| P1476 | title | The Role of Gene Therapy in Cartilage Repair | |
| P478 | volume | 7 |
Search more.